Compounds of the formula (I):
or pharmaceutically acceptable salts thereof, wherein R
1
and R
2
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).
Compounds of the formula (I):
or pharmaceutically acceptable salts thereof, wherein R
1
and R
2
are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).